Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Cervical cancer screening should be done by primary HPV testing with genotyping and reflex cytology for women over the age of 25 years.

Stoler MH, Austin RM, Zhao C.

J Clin Microbiol. 2015 May 6. pii: JCM.01087-15. [Epub ahead of print]

PMID:
25948606
2.

Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.

Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS.

Cancer Cytopathol. 2015 May;123(5):282-8. doi: 10.1002/cncy.21544. Epub 2015 Apr 10.

PMID:
25864682
3.

Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results.

Barron S, Austin RM, Li Z, Zhao C.

Am J Clin Pathol. 2015 Apr;143(4):485-91. doi: 10.1309/AJCPU57UELKUZCYY.

PMID:
25779999
4.
5.

Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?

Austin RM, Zhao C.

Cytojournal. 2014 May 22;11:14. doi: 10.4103/1742-6413.132997. eCollection 2014. Review.

6.

Brush cytology of the fallopian tube and implications in ovarian cancer screening.

Lum D, Guido R, Rodriguez E, Lee T, Mansuria S, D'Ambrosio L, Austin RM.

J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):851-6. doi: 10.1016/j.jmig.2014.03.017. Epub 2014 Apr 5.

PMID:
24713115
7.

Ultrasound Guided Core Biopsy versus Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy in Patients with Breast Cancer.

Ganott MA, Zuley ML, Abrams GS, Lu AH, Kelly AE, Sumkin JH, Chivukula M, Carter G, Austin RM, Bandos AI.

ISRN Oncol. 2014 Feb 4;2014:703160. doi: 10.1155/2014/703160. eCollection 2014.

9.

Cytologic findings in experimental in vivo fallopian tube brush specimens.

Rodriguez EF, Lum D, Guido R, Austin RM.

Acta Cytol. 2013;57(6):611-8. doi: 10.1159/000353825. Epub 2013 Oct 1.

PMID:
24107657
10.

Abdominopelvic washings: A comprehensive review.

Rodriguez EF, Monaco SE, Khalbuss W, Austin RM, Pantanowitz L.

Cytojournal. 2013 Apr 24;10:7. doi: 10.4103/1742-6413.111080. Print 2013.

11.

Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.

Zhao C, Li Z, Austin RM.

Am J Clin Pathol. 2013 Jul;140(1):47-54. doi: 10.1309/AJCPIP9M8HPVBSSC.

13.

Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results.

Zhao C, Weng B, Li Z, Yang H, Austin RM.

Am J Clin Pathol. 2013 Jan;139(1):32-8. doi: 10.1309/AJCP4DF7ACLBFFGY.

14.

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.

Naryshkin S, Austin RM.

Drug Healthc Patient Saf. 2012;4:167-72. doi: 10.2147/DHPS.S37273. Epub 2012 Nov 2.

15.

Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.

Zhao C, Amin M, Weng B, Chen X, Kanbour-Shakir A, Austin RM.

Arch Pathol Lab Med. 2013 Jul;137(7):942-7. doi: 10.5858/arpa.2012-0307-OA. Epub 2012 Oct 10.

PMID:
23050808
16.

Follow-up outcomes in a large cohort of patients with human papillomavirus-negative ASC-H cervical screening test results.

Cohen D, Austin RM, Gilbert C, Freij R, Zhao C.

Am J Clin Pathol. 2012 Oct;138(4):517-23.

17.

Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.

Li Z, Austin RM, Guo M, Zhao C.

Arch Pathol Lab Med. 2012 Dec;136(12):1533-40. doi: 10.5858/arpa.2011-0609-OA. Epub 2012 Aug 20.

PMID:
22900617
18.

Heavy cervical cancer burden in elderly women: how can we improve the situation?

Skaznik-Wikiel ME, Sukumvanich P, Austin RM, Zorn KK, Krivak TC, Edwards RP, Olawaiye AB.

Acta Cytol. 2012;56(4):388-93. doi: 10.1159/000338555. Epub 2012 Jul 25.

PMID:
22846717
19.

ATHENA trial CIN 2+ cervical biopsy misclassifications raise questions.

Austin RM.

Am J Clin Pathol. 2012 Jun;137(6):1012. doi: 10.1309/AJCPMRVTJ8IP1LWH. No abstract available.

20.

American Society of Cytopathology workload recommendations for automated Pap test screening: developed by the productivity and quality assurance in the era of automated screening task force.

Elsheikh TM, Austin RM, Chhieng DF, Miller FS, Moriarty AT, Renshaw AA; American Society of Cytopathology.

Diagn Cytopathol. 2013 Feb;41(2):174-8. doi: 10.1002/dc.22817. Epub 2012 Feb 20.

PMID:
22351120
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk